(Reuters) – CVS Health Corp reported a 10.5% rise in first-quarter profit on Tuesday, helped in part by higher sales at its drug stores, with more customers seeking COVID-19 tests and vaccinations.
The company has been offering COVID-19 tests and vaccines as part of the ongoing federal program, which CVS hopes will increase footfall at its drug stores.
CVS Health’s net profit rose to $2.22 billion, or $1.68 per share, in the reported quarter, from $2.01 billion, or $1.53 per share, a year earlier.
Sales rose to $69.1 billion from $66.76 billion.
(Reporting by Manojna Maddipatla and Mrinalika Roy in Bengaluru; Editing by Shounak Dasgupta)
